Advanced Search

Publications > Journals > Journal of Clinical and Translational Hepatology > About the journal

Sponsored by
Second Affiliated Hospital of Chongqing Medical University
About the journal
Aims and Scope

The Journal of Clinical and Translational Hepatology (JCTH) is owned by the Second Affiliated Hospital of Chongqing Medical University and published by XIA & HE Publishing Inc. JCTH publishes high quality, peer reviewed studies in the translational and clinical human health sciences of liver diseases. JCTH has established high standards for publication of original research, which are characterized by a study’s novelty, quality, and ethical conduct in the scientific process as well as in the communication of the research findings. Each issue includes articles by leading authorities on topics in hepatology that are germane to the most current challenges in the field. Special features include reports on the latest advances in drug development and technology that are relevant to liver diseases. Regular features of JCTH also include editorials, correspondences and invited commentaries on rapidly progressing areas in hepatology. All articles published by JCTH, both solicited and unsolicited, must pass our rigorous peer review process.

The open access publishing model used by JCTH avails all publications to an international readership audience, prompting worldwide interest from contributing authors and helping to promote the diverse range in hepatology topics covered in our journal. JCTH welcomes submissions of articles within its topical scope, which includes:

  • Novel discoveries in translational and clinical hepatology
  • Liver disease mechanisms
  • Novel techniques in research and management of liver diseases
  • Epidemiological/environmental factors of liver diseases
  • Role of immune system function in liver diseases
  • Acute and chronic hepatitis
  • Cirrhosis
  • Genetic and metabolic liver diseases and their complications
  • Hepatobiliary diseases
  • Liver cancer
  • Drug metabolism
  • Billary disease
  • Peritoneal tubeculosis
Open Access

Journal of Clinical and Translational Hepatology (JCTH) adopts open access publishing model, and all articles are distributed under the terms of the CC BY-NC 4.0 license (http://creativecommons.org/licenses/by-nc/4.0/). Under this license, anyone may copy, distribute, or reuse these articles for non-commercial purposes, provided the original work is properly cited. Manuscripts submitted for publication in an open access journal are subject to the same rigorous peer-review and quality control as in scholarly subscription journals.

JCTH recognizes the distinct advantages of using an open access publication model to promote the timely dissemination of innovative and important research findings. Unrestricted free access to our publications is anticipated to foster intellectual discourse across geographic and disciplinary boundaries. To support the success of our open access approach, we ensure the integrity and high quality of research published in our journal by practicing a rigorous peer review process and by following strict guidelines for ethics in publication and in conduct of the scientific process.

Publication Criteria

All manuscripts submitted to the Journal of Clinical and Translational Hepatology must meet the following criteria for publication:

  • Original research in the clinical or basic sciences of hepatology
  • Results and findings that have not been previously published elsewhere
  • Topics with timely relevance to the general field or specialties of hepatology
  • Research performed with adherence to accepted global standards for ethics in the scientific process
  • Ethical reporting of data to protect the rights and privacy of study participants
  • Appropriate statistical analyses, with sufficient descriptions of all statistical methods used
  • Conclusions supported by the data presented
  • All funding sources and their roles cited
  • For clinical trials, the registration number cited
  • Manuscript written in standard American (US) English and formatted according to the journal-specific guidelines
  • No instances of textual plagiarism, including ‘text recycling/self-plagiarism”
Publishing Schedule

From November 2023, JCTH is published monthly.

Journal Metrics

JCTH Metrics (2023)
Acceptance rate: 15% 
Median time from submission to first decision: 32 days 
Median time from acceptance to online publishing: 25 days
Impact Factor 2023: 3.1, CiteScore 2023: 6.4

Revenue Sources

JCTH adopts the open access publishing model. JCTH is mostly financially supported by the Second Affiliated Hospital of Chongqing Medical University, with limited revenue of article processing charges (APC) from authors or their institutions, permissions, and reprints.

Contact Us

Editorial Office

Managing Editors: Dr. Huaidong Hu, Dr. Zhi Peng, Dr. Sandeep Kumar Karn
Tel: +86-23-6370 1383
Fax: +86-23-6370 1383
E-mail: [email protected] 
Postal Address: 74 Linjiang Road, Yuzhong District, 400010 Chongqing, China


Xia & He Publishing Inc.
Website: www.xiahepublishing.com
Tel: +1-409-420-2868
E-mail: [email protected]

US Office
Address: 14090 Southwest Freeway, Suite 300, Sugar Land, Texas 77478, USA

China Office
Address: Room 505, Building B1, Bio-innovation Park, No. 666 High-tech Road, East Lake High-tech Development Zone, Wuhan, China

Back to Top